Fundraising FoxOligomerix
White Plains, US · Delaware corporation
Find your way into Oligomerix
Sign up to see every warm intro you have to Oligomerix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Oligomerix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
ED
Eliot DavidowitzCo-founder
JM
James MoeCo-founderJames Moe is President and CEO of Oligomerix, a Bronx, NY-based company developing tau-targeting therapeutics for Alzheimer's and other tauopathies, including its lead compound OLX-07010. He holds a Ph.D. in molecular biology and biochemistry from Wesleyan University, completed postdoctoral studies at Vanderbilt University, and previously worked at Q-RNA, Amoco Technology Group/Gene-Trak/Vysis, and bioMérieux on probe-based diagnostics.
WE
William ErhardtExecutive
RF
Robert FoersterExecutive
Board
DD
David DantzkerBoard director
DD
Douglas DurandBoard director
JB
Jeffrey BluesteinBoard director
VM
Victor MicatiBoard director
Reported raises · per SEC filings
Form D private placements$2.9M disclosed across 3 of 4 rounds · 2012–2024
▶$75KraisedDec 2024 · 3 investors · PharmaceuticalsRule 506(b)
▶$75KraisedDec 2024 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Douglas DurandDirector
- William ErhardtExecutive Officer, Director
- Robert FoersterExecutive Officer, Director
- Jeffrey BluesteinDirector
- Eliot DavidowitzExecutive Officer, Director
- James MoeExecutive Officer, Director
- David DantzkerDirector
- Jack PasiniExecutive Officer, Director
- Offering amount
- $650K
- Amount sold
- $75K
- First sale
- Nov 2024
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.4MraisedMar 2022 · 12 investors · PharmaceuticalsRule 506(b)
▶$2.4MraisedMar 2022 · 12 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey BluesteinDirector
- Robert ForesterExecutive Officer
- Douglas DurandDirector
- Jack PasiniDirector
- James MoeExecutive Officer, Director
- David DantzkerDirector
- William ErhardtDirector
- Victor MicatiDirector
- Eliot DavidowitzDirector
- Offering amount
- $3.5M
- Amount sold
- $2.4M
- Proceeds to insiders
- $650K
- First sale
- Mar 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$400KraisedApr 2015 · 2 investors · PharmaceuticalsRule 506(b)
▶$400KraisedApr 2015 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey BluesteinDirector
- Douglas DurandDirector
- Jack PasiniDirector
- James MoeExecutive Officer, Director
- David DantzkerDirector
- Victor MicatiDirector
- Offering amount
- $3M
- Amount sold
- $400K
- Proceeds to insiders
- $200K
- First sale
- Apr 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.7MofferedMar 2012 · PharmaceuticalsRule 506(b)
▶$2.7MofferedMar 2012 · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- David DantzkerDirector
- Douglas DurandDirector
- James MoeExecutive Officer, Director
- Jack PasiniDirector
- Victor MicatiDirector
- Offering amount
- $2.7M
- Minimum investment
- $25K
- Proceeds to insiders
- $94.5K
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who founded Oligomerix?
- Oligomerix was founded by Eliot Davidowitz, James Moe.
- How much funding has Oligomerix raised?
- Oligomerix has disclosed $2.9M raised across 3 of its 4 known rounds.
- Where is Oligomerix headquartered?
- Oligomerix is headquartered in White Plains, US.